The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Open accessAbstract
Neurodegenerative diseases are conventionally demarcated as disorders with selective loss of neurons. Conventional as well as newer molecules have been tested but they offer just symptomatic advantages along with abundant side effects. The discovery of more compelling molecules that can halt the pathology of these diseases will be considered as a miracle of present time. Several synthetic compounds are available but they may cause several other health issues. Therefore, natural molecules from the plants and other sources are being discovered to replace available medicines. In conventional medicational therapies, several plants have been reported to bestow remedial effects. Phytochemicals from medicinal plants can provide a better and safer alternative to synthetic molecules. Many phytochemicals have been identified that cure the human body from a number of diseases. The present article reviews the potential efficacy of plant-derived alkaloids, which possess potential therapeutic effects against several NDDs including Alzheimer's disease (AD), Huntington disease (HD), Parkinson's disease (PD), Epilepsy, Schizophrenia, and stroke. Alkaloids include isoquinoline, indole, pyrroloindole, oxindole, piperidine, pyridine, aporphine, vinca, β-carboline, methylxanthene, lycopodium, and erythrine byproducts. Alkaloids constitute positive roles in ameliorating pathophysiology of these illnesses by functioning as muscarinic and adenosine receptors agonists, anti-oxidant, anti-amyloid and MAO inhibitors, acetylcholinestrase and butyrylcholinesterase inhibitor, inhibitor of α-synuclein aggregation, dopaminergic and nicotine agonist, and NMDA antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Powers, W. J., Derdeyn, C. P., Biller, J., Coffey, C. S., Hoh, B. L., Jauch, E. C., Johnston, K. C., Johnston, S. C., Khalessi, A. A., Kidwell, C. S., et al. (2015) · Stroke · doi:10.1161/str.0000000000000074 · Cited by 2,124
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Alzheimer's disease: Targeting the Cholinergic System
H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551
Neuropsychiatric Disease and Treatment
(2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt · Cited by 1,179
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,124
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Role of oxidative stress in Alzheimer’s disease
HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023
2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies
Ciechanover, A., & Kwon, Y. T. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.117 · Cited by 898
Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities
Cushnie, T. P. T., Cushnie, B., & Lamb, A. J. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.06.001 · Cited by 894
Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870
Prediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
Cotter, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.386 · Cited by 634
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Yan, R., & Vassar, R. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70276-x · Cited by 630
Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
Neuroprotective potential of phytochemicals
Kumar, G., & Khanum, F. (2012) · Pharmacognosy Reviews · doi:10.4103/0973-7847.99898 · Cited by 511
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
Cooper, J. M., Wiklander, P. B. O., Nordin, J. Z., Al‐Shawi, R., Wood, M. J., Vithlani, M., Schapira, A. H. V., Simons, J. P., El‐Andaloussi, S., & Alvarez‐Erviti, L. (2014) · Movement Disorders · doi:10.1002/mds.25978 · Cited by 507
Dopaminergic neurons promote hippocampal reactivation and spatial memory persistence
McNamara, C. G., Tejero-Cantero, Á., Trouche, S., Campo-Urriza, N., & Dupret, D. (2014) · Nature Neuroscience · doi:10.1038/nn.3843 · Cited by 486
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Dineley, K. T., Pandya, A. A., & Yakel, J. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.002 · Cited by 450
Palfi, S., Gurruchaga, J. M., Ralph, G. S., Lepetit, H., Lavisse, S., Buttery, P. C., Watts, C., Miskin, J., Kelleher, M., Deeley, S., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61939-x · Cited by 450
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane, Tatiani, Francielle, Michelle, & Alexandra (2015) · Aging and disease · doi:10.14336/ad.2015.0825 · Cited by 407
Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T., & Bezard, E. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61010-2 · Cited by 392
Autophagy in Huntington disease and huntingtin in autophagy
Martin, D. D. O., Ladha, S., Ehrnhoefer, D. E., & Hayden, M. R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.09.003 · Cited by 350
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., et al. (2016) · Nature · doi:10.1038/nature17188 · Cited by 335
Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
Baranello, R., Bharani, K., Padmaraju, V., Chopra, N., Lahiri, D., Greig, N., Pappolla, M., & Sambamurti, K. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218140953 · Cited by 331
The Prevalence of Huntington's Disease
Rawlins, M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016) · Neuroepidemiology · doi:10.1159/000443738 · Cited by 331
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment
Lombardo, S., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.018 · Cited by 299
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 258
The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes
Nhan, H. S., Chiang, K., & Koo, E. H. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1347-2 · Cited by 256
Application of Berberine on Treating Type 2 Diabetes Mellitus
Pang, B., Zhao, L.-H., Zhou, Q., Zhao, T.-Y., Wang, H., Gu, C.-J., & Tong, X.-L. (2015) · International Journal of Endocrinology · doi:10.1155/2015/905749 · Cited by 251
Abd El-Wahab, A. E., Ghareeb, D. A., Sarhan, E. E., Abu-Serie, M. M., & El Demellawy, M. A. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-218 · Cited by 250
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
Pohanka, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069809 · Cited by 245
Yang, G., Wang, Y., Tian, J., & Liu, J.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074916 · Cited by 241
A Review on Therapeutic Potential of Piper nigrum L. (Black Pepper): The King of Spices
Damanhouri, Z. A. (2014) · Medicinal & Aromatic Plants · doi:10.4172/2167-0412.1000161 · Cited by 240
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Snyder, M. A., & Gao, W.-J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00031 · Cited by 236
Plant alkaloids as drug leads for Alzheimer's disease
Ng, Y. P., Or, T. C. T., & Ip, N. Y. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.018 · Cited by 234
Crook, J. M., Tomaskovic-Crook, E., Copolov, D. L., & Dean, B. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00918-5 · Cited by 228
Mayer, B. (2014) · Archives of Toxicology · doi:10.1007/s00204-013-1127-0 · Cited by 224
Konrath, E. L., Passos, C. D. S., Klein-Júnior, L. C., & Henriques, A. T. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12090 · Cited by 217
Akl, H., Vervloessem, T., Kiviluoto, S., Bittremieux, M., Parys, J. B., De Smedt, H., & Bultynck, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.04.017 · Cited by 215
Collin, L., Bohrmann, B., Göpfert, U., Oroszlan-Szovik, K., Ozmen, L., & Grüninger, F. (2014) · Brain · doi:10.1093/brain/awu213 · Cited by 208
Effects of coffee/caffeine on brain health and disease: What should I tell my patients?
Nehlig, A. (2016) · Practical Neurology · doi:10.1136/practneurol-2015-001162 · Cited by 205
Akaike, A., Takada-Takatori, Y., Kume, T., & Izumi, Y. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9236-1 · Cited by 202
Rivera-Oliver, M., & Díaz-Ríos, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.083 · Cited by 202
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Müller, C. E., Buée, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.027 · Cited by 195
Association between cigarette smoking and Parkinson’s disease: A meta-analysis
Li, X., Li, W., Liu, G., Shen, X., & Tang, Y. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.08.004 · Cited by 189
Self-citationLu, J.-H., Tan, J.-Q., Durairajan, S. S. K., Liu, L.-F., Zhang, Z.-H., Ma, L., Shen, H.-M., Chan, H. Y. E., & Li, M. (2012) · Autophagy · doi:10.4161/auto.8.1.18313 · Cited by 184
Alpha-synuclein spreading in Parkinson’s disease
Recasens, A., & Dehay, B. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00159 · Cited by 180
The pharmacology, toxicology and potential applications of arecoline: a review
Liu, Y.-J., Peng, W., Hu, M.-B., Xu, M., & Wu, C.-J. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2016.1160251 · Cited by 175
Pharmacological effects of berberine and its derivatives: a patent update
Jin, Y., Khadka, D. B., & Cho, W.-J. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118060 · Cited by 174
Huang, M., Jiang, X., Liang, Y., Liu, Q., Chen, S., & Guo, Y. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.02.004 · Cited by 172
Selective MAO-B inhibitors: a lesson from natural products
Carradori, S., D’Ascenzio, M., Chimenti, P., Secci, D., & Bolasco, A. (2013) · Molecular Diversity · doi:10.1007/s11030-013-9490-6 · Cited by 164
Medicinal compounds with antiepileptic/anticonvulsant activities
Zhu, H., Wan, J., Wang, Y., Li, B., Xiang, C., He, J., & Li, P. (2014) · Epilepsia · doi:10.1111/epi.12463 · Cited by 162
Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy
Hirose, S. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00003-x · Cited by 162
Kim, M., Cho, K., Shin, M., Lee, J. M., Cho, H.-S., Kim, C., SHIN, D.-H., & Yang, H. J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1656 · Cited by 159
Role of berberine in Alzheimer’s disease
Cai, Z., Wang, C., & Yang, W. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114846 · Cited by 159
Levy, D. T., Cummings, K. M., Villanti, A. C., Niaura, R., Abrams, D. B., Fong, G. T., & Borland, R. (2017) · Addiction · doi:10.1111/add.13394 · Cited by 158
Chen, C., Yu, Z., Li, Y., Fichna, J., & Storr, M. (2014) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x14500669 · Cited by 151
Godugu, C., Patel, A. R., Doddapaneni, R., Somagoni, J., & Singh, M. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089919 · Cited by 150
McIntire, L. K., McKinley, R. A., Goodyear, C., & Nelson, J. M. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.04.008 · Cited by 148
Anti-apoptotic and Anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's Rat model
Shrivastava, P., Vaibhav, K., Tabassum, R., Khan, A., Ishrat, T., Khan, M. M., Ahmad, A., Islam, F., Safhi, M. M., & Islam, F. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.03.018 · Cited by 146
Bhattacharya, S., Haertel, C., Maelicke, A., & Montag, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089454 · Cited by 142 · cited 1×
“But it has also been considered that the long term use of galantamine can significantly attenuate the mortality [105].”
BackgroundHriţcu, L., Noumedem, J. A. K., Cioancă, O., Hăncianu, M., Kuete, V., & Mihăşan, M. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0028-y · Cited by 139
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease
Sepers, M. D., & Raymond, L. A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.006 · Cited by 133
Setti-Perdigão, P., Serrano, M. A. R., Flausino, O., Bolzani, V. D. S., Guimarães, M. Z. P., & Castro, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082726 · Cited by 130
A plural role for lipids in motor neuron diseases: energy, signaling and structure
Schmitt, F., Hussain, G., Dupuis, L., Loeffler, J., & Henriques, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00025 · Cited by 130
Self-citationBarreto, G. E., Iarkov, A., & Echeverría, V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00340 · Cited by 122
Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
Jiang, W., Wei, W., Gaertig, M. A., Li, S., & Li, X.-J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134142 · Cited by 121
Self-citationIschemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke
Wang, Y., Reis, C., Applegate, R. L., Stier, G. R., Martin, R., & Zhang, J. H. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.009 · Cited by 120
Huperzine A in the Treatment of Alzheimer′s Disease and Vascular Dementia: A Meta‐Analysis
Xing, S.-H., Zhu, C., Zhang, R., & An, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/363985 · Cited by 117
Kharkwal, G., Brami‐Cherrier, K., Lizardi-Ortiz, J. E., Nelson, A., Ramos, M., Barrio, D. D., Sulzer, D., Kreitzer, A. C., & Borrelli, E. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.014 · Cited by 115
ALKALOIDS-IMPORTANT THERAPEUTIC SECONDARY METABOLITES OF PLANT ORIGIN
Kaur, R., & Arora, S. (2015) · Journal of Critical Reviews · Cited by 114
Kamagata, K., Tomiyama, H., Hatano, T., Motoi, Y., Abe, O., Shimoji, K., Kamiya, K., Suzuki, M., Hori, M., Yoshida, M., et al. (2014) · Neuroradiology · doi:10.1007/s00234-014-1327-1 · Cited by 110
He, D., Wu, H., Wei, Y., Liu, W., Huang, F., Shi, H., Zhang, B., Wu, X., & Wang, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.037 · Cited by 105
Fatting the brain: a brief of recent research
Hussain, G., Schmitt, F., Loeffler, J., & de Aguilar, J. G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00144 · Cited by 103
Self-citationAnticonvulsant mechanisms of piperine, a piperidine alkaloid
Mishra, A., Punia, J. K., Bladen, C., Zamponi, G. W., & Goel, R. K. (2015) · Channels · doi:10.1080/19336950.2015.1092836 · Cited by 96
Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia
Deng, C., & Huang, X. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20600 · Cited by 96
In vitro production of huperzine A, a promising drug candidate for Alzheimer’s disease
Ma, R., & Gang, D. R. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.04.017 · Cited by 96
Therapeutic potential of berberine against neurodegenerative diseases
Jiang, W., Li, S., & Li, X. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4829-0 · Cited by 94
Self-citationOrhan, G., Orhan, I., Subutay-Oztekin, N., Ak, F., & Sener, B. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909787002582 · Cited by 90
The muscarinic system, cognition and schizophrenia
Carruthers, S. P., Gurvich, C. T., & Rossell, S. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.011 · Cited by 90
Zhang, H., Bai, L., He, J., Zhong, L., Duan, X., Ouyang, L., Zhu, Y., Wang, T., Zhang, Y., & Shi, J. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.068 · Cited by 90
Harmine stimulates proliferation of human neural progenitors
Dakic, V., Maciel, R. D. M., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. (2016) · PeerJ · doi:10.7717/peerj.2727 · Cited by 88
Nikiforuk, A., Kos, T., Potasiewicz, A., & Popik, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.018 · Cited by 87
Calcium signaling and epilepsy
Steinlein, O. K. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1849-1 · Cited by 87
Yeggoni, D. P., Rachamallu, A., Kallubai, M., & Subramanyam, R. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.947326 · Cited by 86
Huperzine A Ameliorates Cognitive Deficits in Streptozotocin-Induced Diabetic Rats
Mao, X., Cao, D., Li, X., Yin, J., Wang, Z., Zhang, Y., Mao, C., Zhou, H., & Liu, Z. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057667 · Cited by 86
Self-citationXian, Y., Mao, Q., Wu, J. C., Su, Z., Chen, J., Lai, X., Ip, S., & Lin, Z. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131457 · Cited by 85
Cortés, N., Posada‐Duque, R., Álvarez, R., Álzate, F., Berkov, S. H., Cardona‐Gómez, G. P., & Osorio, E. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.011 · Cited by 85
Protective Effect of Isorhynchophylline Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Xian, Y., Lin, Z., Mao, Q., Ip, S., Su, Z., & Lai, X. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9763-5 · Cited by 84
Kita, Y., Ago, Y., Higashino, K., Asada, K., Takano, E., Takuma, K., & Matsuda, T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000613 · Cited by 84
Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients
Zhang, F., Chen, Y., Wei, C., Yao, Y., Ma, X., Gong, Z., Liu, S., Zang, D., Chen, J., Shi, F., et al. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0549-z · Cited by 83
The Longitudinal Evolution of Cerebral Blood Flow Regulation after Acute Ischaemic Stroke
Salinet, A. S. M., Panerai, R. B., & Robinson, T. G. (2014) · Cerebrovascular Diseases Extra · doi:10.1159/000366017 · Cited by 79
Patil, S., Tawari, S., Mundhada, D. R., & Sayyed, N. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.001 · Cited by 76
Huperzine A promotes hippocampal neurogenesis in vitro and in vivo
Ma, T., Gong, K., Yan, Y., Zhang, L., Tang, P., Zhang, X., & Gong, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.026 · Cited by 76
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease
Baseman, A. S., Häger, K., Nye, J. S., Brashear, R. H., Han, J., Sano, M., Davis, B. M., & Richards, H. M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s57909 · Cited by 74
Cui, J., Wang, Y.-F., Dong, Q., Wu, S., Xiao, X., Hu, J., Chai, Z., & Zhang, Y. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3915-11.2011 · Cited by 74
Mohamed, L. A., Keller, J. N., & Kaddoumi, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.013 · Cited by 70
Al-Baghdadi, O. B., Prater, N. I., der Schyf, C. J. V., & Geldenhuys, W. J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.056 · Cited by 69
Golechha, M., Sarangal, V., Bhatia, J., Chaudhry, U., Saluja, D., & Arya, D. S. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.09.058 · Cited by 67
Tundis, R., Menichini, F., Conforti, F., Loizzo, M. R., Bonesi, M., Statti, G. A., & Menichini, F. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360802399662 · Cited by 67
Pagliosa, L. B., Monteiro, S. C., Silva, K. B., de Andrade, J. P., Dutilh, J., Bastida, J., Cammarota, M., & Zuanazzi, J. Â. S. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.10.003 · Cited by 64
Zhang, Q., Bian, H., Guo, L., & Zhu, H. (2016) · PubMed · Cited by 64
Mikkilineni, S., Cantuti‐Castelvetri, I., Cahill, C. M., Balliedier, A., Greig, N. H., & Rogers, J. T. (2012) · Parkinson s Disease · doi:10.1155/2012/142372 · Cited by 62
Ho, T., Tang, N.-Y., Hsiang, C., & Hsieh, C. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.01.011 · Cited by 58
Rocha, L., Alonso‐Vanegas, M., Martínez-Juárez, I. E., Orozco-Suárez, S. A., Escalante-Santiago, D., Feria-Romero, I. A., Zavala‐Tecuapetla, C., Cisneros-Franco, J. M., Buentello-García, R. M., & Cienfuegos-Meza, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00442 · Cited by 57
Berberine Promotes Axonal Regeneration in Injured Nerves of the Peripheral Nervous System
Han, A. M., Heo, H., & Kwon, Y. K. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2011.2029 · Cited by 56
Rinwa, P., & Kumar, A. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0205-4 · Cited by 53
Screening of β-secretase and acetylcholinesterase inhibitors from plant resources
Murata, K., Matsumura, S., Yoshioka, Y., et al. (2014) · Journal of Natural Medicines · doi:10.1007/s11418-014-0859-3 · Cited by 52
Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
Shaikh, S., Verma, A., Siddiqui, S., et al. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660166 · Cited by 52
Activation of CXCL10/CXCR3 Signaling Attenuates Morphine Analgesia: Involvement of Gi Protein
Ye, D., Bu, H., Guo, G., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0223-1 · Cited by 50
Mojarad, T. B., & Roghani, M. (2014) · Europe PMC (PubMed Central) · Cited by 50
Neurobiology of Schizophrenia Onset
Woo, T.-U. W. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_243 · Cited by 49
Ratia, M., Giménez‐Llort, L., Camps, P., Muñoz‐Torrero, D., Pérez, B., Clos, M. V., & Badía, A. (2012) · Neurodegenerative Diseases · doi:10.1159/000336427 · Cited by 49
Ruiz-Miyazawa, K. W., Zarpelon, A. C., Pinho-Ribeiro, F. A., Pavão-de-Souza, G. F., Casagrande, R., & Verri, W. A., Jr. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118942 · Cited by 49
Kwon, J., Seo, Y. H., Lee, J.-E., Seo, E. K., Li, S., Guo, Y., Hong, S., Park, S., & Lee, D. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00508 · Cited by 48
Tie, H., Su, G.-Z., He, K., Liang, S.-R., Yuan, H.-W., & Mou, J. (2014) · BMC Anesthesiology · doi:10.1186/1471-2253-14-12 · Cited by 48
Pathophysiology and Biomarkers in Acute Ischemic Stroke – A Review
Guo, Y. H., Li, P., Guo, Q. J., Shang, K., Yan, D., Du, S., & Lu, Y. (2014) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i6.35 · Cited by 48
Bales, A., Peterson, M. J., Ojha, S. P., Upadhaya, K., Adhikari, B., & Barrett, B. P. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.006 · Cited by 47
Current Concepts of Neurodegenerative Diseases
Kovács, G. G. (2014) · EMJ Neurology · doi:10.33590/emjneurol/10314777 · Cited by 47
Araújo, J. Q., Lima, J. A., Pinto, Â. D. C., de Alencastro, R. B., & Albuquerque, M. G. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-010-0841-2 · Cited by 45
The Role of Oxidative Stress in Alzheimer ’ s Disease
Madeo, J. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000116 · Cited by 45
Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model
Assche, R. V., Temmerman, L., Dias, D. A., Boughton, B. A., Boonen, K., Braeckman, B. P., Schoofs, L., & Roessner, U. (2014) · Metabolomics · doi:10.1007/s11306-014-0711-5 · Cited by 44
Klein‐Júnior, L. C., Passos, C. D. S., Moraes, A. P., Wakui, V. G., Konrath, E. L., Nurisso, A., Carrupt, P., de Oliveira, C. A., Kato, L., & Henriques, A. T. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140324142409 · Cited by 44
μ‐Opioid Receptor Attenuates Aβ Oligomers‐Induced Neurotoxicity Through mTOR Signaling
Wang, Y., Wang, Y., Liu, T., Law, P., Loh, H. H., Qiu, Y. L., & Chen, H. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12316 · Cited by 43
Shao, Z. (2015) · PubMed · Cited by 42
Plant derived alkaloids in major neurodegenerative diseases: from animal models to clinical trials
Girdhar, S., Girdhar, A., Verma, S. K., Lather, V., & Pandita, D. (2015) · Journal of Ayurvedic and Herbal Medicine · doi:10.31254/jahm.2015.1307 · Cited by 41
Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: A review
Coppola, M., & Mondola, R. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.605172 · Cited by 40
Hussain, G., Schmitt, F., Henriques, A., Lequeu, T., René, F., Bindler, F., Dirrig‐Grosch, S., Oudart, H., Palamiuc, L., Metz‐Boutigue, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064525 · Cited by 40
Self-citationImenshahidi, M., Qaredashi, R., Hashemzaei, M., & Hosseinzadeh, H. (2014) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.17795/jjnpp-16145 · Cited by 40
Pelissier-Rota, M. A., Pélosi, L., Méresse, P., & Jacquier‐Sarlin, M. R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.013 · Cited by 39
Berger, J. S., Gonzalez, A., Hopkins, A. N., et al. (2016) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2016.08.003 · Cited by 39
Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A) Enhances Tau Expression
Qian, W., Jin, N., Shi, J., Yin, X., Jin, X., ShiBao, W., Cao, M., Iqbal, K., Gong, C., & Liu, F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130824 · Cited by 38
Grizzell, J. A., Patel, S. P., Barreto, G. E., & Echeverría, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.010 · Cited by 38
Bioavailability Enhancement by Piperine: A Review
Wadhwa, S., Singhal, S., & Rawat, S. S. (2014) · Asian journal of biomedical and pharmaceutical sciences · doi:10.15272/ajbps.v4i36.576 · Cited by 35
Zhou, J., Sun, Q., Yang, Z., & Zhang, J. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.2.143 · Cited by 35
The Brazilian Amaryllidaceae as a source of acetylcholinesterase inhibitory alkaloids
de Andrade, J. P., Giordani, R. B., Torras‐Claveria, L., Pigni, N. B., Berkov, S. H., Font‐Bardía, M., Calvet, T., Konrath, E. L., Bueno, K. S. D. S., Sachett, L. G., et al. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9411-7 · Cited by 34
Adilijiang, A., Guan, T., He, J., Hartle, K. D., Wang, W., & Li, X. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/426092 · Cited by 32
Self-citationShim, S. B., Lee, S. H., Chae, K. R., Kim, C. K., Hwang, D. Y., Kim, B. G., Jee, S. W., Lee, S. H., Sin, J. S., Bae, C. J., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9629-5 · Cited by 29
Dimatelis, J. J., Russell, V. A., Stein, D. J., & Daniels, W. M. U. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9288-8 · Cited by 29
Ordoñez, W. O. C., & Aristizábal-Pachón, A. F. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.208572 · Cited by 29
Lobeline Effects on Cognitive Performance in Adult ADHD
Martin, C. A., Nuzzo, P. A., Ranseen, J. D., Kleven, M. S., Guenthner, G., Williams, Y. S., WALSH, S. L., & Dwoskin, L. P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713497791 · Cited by 28
Caramelli, P., Laks, J., Palmini, A., Nitríni, R., Chaves, M. L. F., Forlenza, O. V., do Vale, F. D. A. C., Barbosa, M. T., Bottino, C. M. D. C., Machado, J. C., et al. (2014) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20140055 · Cited by 28
Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
Kim, J. K., & Park, S. U. (2017) · EXCLI journal · doi:10.17179/excli2016-820 · Cited by 28
Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia
Jincai, W., Tingfang, D., Zhang, Y., Zhongmin, L., Kaihua, Z., & Xiaohong, L. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.07.039 · Cited by 25
Ding, X., Jin, S., Niu, X., Wang, T., Zhao, X., Ren, H., Tong, Y., & Li, Q. (2014) · PubMed Central · Cited by 25
Cortical gray matter loss in schizophrenia: Could microglia be the culprit?
Rački, V., Petrić, D., Kučić, N., Gržeta, N., Jurdana, K., & Rončević-Gržeta, I. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2015.12.021 · Cited by 22
Glutamate Receptors in Alzheimer’s Disease: Mechanisms and Therapies
Anggono, V., Tsai, L., & Götz, J. (2016) · Neural Plasticity · doi:10.1155/2016/8256196 · Cited by 22
Ghafari, S., & Golalipour, M. J. (2014) · PubMed Central · Cited by 20
Sajkowska‐Kozielewicz, J. J., Kozielewicz, P., Barnes, N. M., Wawer, I., & Paradowska, K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2573580 · Cited by 20
Factors affecting therapeutic response to Rivastigmine in Alzheimer's disease patients in Taiwan
Chen, T., Chou, M., Lai, C., Wu, S., Hsu, C., & Yang, Y. (2017) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2017.04.006 · Cited by 16
The Level of NMDA Receptor in the Membrane Modulates Amyloid-β Association and Perforation
Peters, C., Sepúlveda, F. J., Fernández-Pérez, E. J., Peoples, R. W., & Aguayo, L. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160170 · Cited by 15
Antinociceptive and anti-inflammatory effects of a Geissospermum vellosii stem bark fraction
Lima, J. A., da Costa, T. W. R., Silva, L. L., Miranda, A. L. P., & Pinto, A. C. (2016) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140374 · Cited by 13
Fuentealba, J., & Sáez-Orellana, F. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.145349 · Cited by 6
Cited by
Role of cholesterol and sphingolipids in brain development and neurological diseases
Hussain, G., Wang, J., Rasul, A., Anwar, H., Imran, A., Qasim, M., Zafar, S., Kamran, S. K. S., Razzaq, A., Aziz, N., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0965-z · Cited by 378
Self-citationHussain, G., Wang, J., Rasul, A., Anwar, H., Qasim, M., Zafar, S., Aziz, N., Razzaq, A., Hussain, R., de Aguilar, J.-L. G., et al. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.35653 · Cited by 323
Self-citationBACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Moussa‐Pacha, N. M., Abdin, S. M., Omar, H. A., Alniss, H., & Al‐Tel, T. H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21622 · Cited by 274
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Bhattacharya, T., Soares, G. A. B. E., Chopra, H., Rahman, M. M., Hasan, Z., Swain, S. S., & Cavalu, S. (2022) · Materials · doi:10.3390/ma15030804 · Cited by 259
Ho, T. N. T., Abraham, N., & Lewis, R. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.609005 · Cited by 87
Metadata
- Authors
- Hussain, G., Rasul, A., Anwar, H., Aziz, N., Razzaq, A., Wei, W., Ali, M., Li, J., & Li, X.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 14
- Issue
- 3
- Pages
- 341-357
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2791644413
- Cited by
- 351
- References
- 160
- FWCI
- 35.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.